{"annotations":[{"propAbbrev":"bao:BAO_0000205","descr":"one protein sequence","propLabel":"has assay format","valueLabel":"single protein format","valueURI":"http://www.bioassayontology.org/bao#BAO_0000357","valueAbbrev":"bao:BAO_0000357","propURI":"http://www.bioassayontology.org/bao#BAO_0000205"},{"propAbbrev":"bao:BAO_0002867","descr":"This microplate contains 1536 wells. It is highly miniaturized to accommodate more wells on one plate which reduces the plate handling time and allows working with very small volumes (few microliters) that reduces the cost of an assay.","propLabel":"has assay footprint","valueLabel":"1536 well plate","valueURI":"http://www.bioassayontology.org/bao#BAO_0000516","valueAbbrev":"bao:BAO_0000516","propURI":"http://www.bioassayontology.org/bao#BAO_0002867"},{"propAbbrev":"bao:BAO_0002921","descr":"","propLabel":"has organism","valueLabel":"Human immunodeficiency virus 1","valueURI":"http://purl.obolibrary.org/obo/NCBITaxon_11676","valueAbbrev":"obo:NCBITaxon_11676","propURI":"http://www.bioassayontology.org/bao#BAO_0002921"},{"propAbbrev":"bao:BAO_0002865","descr":"","propLabel":"uses detection instrument","valueLabel":"ViewLux ultraHTS Microplate Imager","valueURI":"http://www.bioassayontology.org/bao#BAO_0000691","valueAbbrev":"bao:BAO_0000691","propURI":"http://www.bioassayontology.org/bao#BAO_0002865"},{"propAbbrev":"bao:BAX_0000006","descr":"The effective concentration of a perturbagen, which produces 50% of the maximal possible response, which could mean either activation (EC50) or inhibition (IC50) for that perturbagen.","propLabel":"has result","valueLabel":"AC50","valueURI":"http://www.bioassayontology.org/bao#BAO_0000186","valueAbbrev":"bao:BAO_0000186","propURI":"http://www.bioassayontology.org/bao#BAX_0000006"},{"propAbbrev":"bao:BAO_0000196","descr":"Reduction of a predefined stimulus. Unit of Measure is always % when normalized to the dynamic range of the assay.","propLabel":"has mode of action","valueLabel":"inhibition","valueURI":"http://www.bioassayontology.org/bao#BAO_0000091","valueAbbrev":"bao:BAO_0000091","propURI":"http://www.bioassayontology.org/bao#BAO_0000196"},{"propAbbrev":"bao:BAO_0000196","descr":"Increase of a predefined stimulus. Unit of Measure is always % when normalized to the dynamic range of the assay.","propLabel":"has mode of action","valueLabel":"activation","valueURI":"http://www.bioassayontology.org/bao#BAO_0000087","valueAbbrev":"bao:BAO_0000087","propURI":"http://www.bioassayontology.org/bao#BAO_0000196"},{"propAbbrev":"bao:BAX_0000002","descr":"Protein-nucleotide interaction","propLabel":"has bioassay type","valueLabel":"protein-nucleotide interaction assay","valueURI":"http://www.bioassayontology.org/bao#BAO_0000394","valueAbbrev":"bao:BAO_0000394","propURI":"http://www.bioassayontology.org/bao#BAX_0000002"},{"propAbbrev":"bao:BAX_0000004","descr":"The packaging of viral RNA (single-stranded or double-stranded) into a nucleocapsid.","propLabel":"has biological process","valueLabel":"viral RNA genome packaging","valueURI":"http://purl.obolibrary.org/obo/GO_0019074","valueAbbrev":"obo:GO_0019074","propURI":"http://www.bioassayontology.org/bao#BAX_0000004"},{"propAbbrev":"bao:BAX_0000005","descr":"An appropriate term could not be found in the underlying ontologies: it may be necessary to create a new one.","propLabel":"has target","valueLabel":"requires term","valueURI":"http://www.bioassayontology.org/bat#RequiresTerm","valueAbbrev":"bat:RequiresTerm","propURI":"http://www.bioassayontology.org/bao#BAX_0000005"},{"propAbbrev":"bao:BAX_0000007","descr":"","propLabel":"has measurement unit","valueLabel":"molar","valueURI":"http://purl.org/obo/owl/UO#UO_0000062","valueAbbrev":"uo:UO_0000062","propURI":"http://www.bioassayontology.org/bao#BAX_0000007"},{"propAbbrev":"bao:BAO_0000210","descr":"Assay performed to confirm activity of compounds identified in the primary screen.  It can be performed as replicate measurements at a single screening concentration or as concentration-response assay.","propLabel":"has assay stage","valueLabel":"confirmatory assay","valueURI":"http://www.bioassayontology.org/bao#BAO_0000030","valueAbbrev":"bao:BAO_0000030","propURI":"http://www.bioassayontology.org/bao#BAO_0000210"},{"propAbbrev":"bao:BAO_0002663","descr":"This property does not apply to this assay.","propLabel":"uses assay kit","valueLabel":"not applicable","valueURI":"http://www.bioassayontology.org/bat#NotApplicable","valueAbbrev":"bat:NotApplicable","propURI":"http://www.bioassayontology.org/bao#BAO_0002663"},{"propAbbrev":"bao:BAO_0000207","descr":"Fluorescence polarization (FP) measurements are based on the assessment of the rotational motions of species. It is used to measure binding interactions. When linear polarized light is used to excite fluorophores, only those aligned with the plane of polarization will be excited. For fluorophores attached to small, rapidly rotating molecules, the initially photoselected orientational distribution becomes randomized prior to emission, resulting in low fluorescence polarization. But binding of the low molecular weight tracer to a large, slowly rotating molecule results in high fluorescence polarization.","propLabel":"has detection method","valueLabel":"fluorescence polarization","valueURI":"http://www.bioassayontology.org/bao#BAO_0000003","valueAbbrev":"bao:BAO_0000003","propURI":"http://www.bioassayontology.org/bao#BAO_0000207"},{"propAbbrev":"bao:BAO_0000185","descr":"The name of a small molecule collection from one source, which can be either commercial or academic, e.g., MLSMR, LOPAC, etc. This collection is generally diverse and contains compounds that modulate diverse biological targets.","propLabel":"has perturbagen","valueLabel":"compound library","valueURI":"http://www.bioassayontology.org/bao#BAO_0000648","valueAbbrev":"bao:BAO_0000648","propURI":"http://www.bioassayontology.org/bao#BAO_0000185"},{"propAbbrev":"bao:BAX_0000012","propLabel":"has protein identity","valueURI":"http://www.bioassayontology.org/protein#247852","valueAbbrev":"protein:247852","propURI":"http://www.bioassayontology.org/bao#BAX_0000012"},{"propAbbrev":"bao:BAO_0002800","descr":"This property does not apply to this assay.","propLabel":"is cell line of","valueLabel":"not applicable","valueURI":"http://www.bioassayontology.org/bat#NotApplicable","valueAbbrev":"bat:NotApplicable","propURI":"http://www.bioassayontology.org/bao#BAO_0002800"},{"propAbbrev":"bao:BAX_0000010","descr":"\nA viral infectious disease that results_in destruction of immune system, leading to life-threatening opportunistic infections and cancers, has_material_basis_in Human immunodeficiency virus 1 or has_material_basis_in Human immunodeficiency virus 2, which are transmitted_by sexual contact, transmitted_by transfer of blood, semen, vaginal fluid, pre-ejaculate, or breast milk, transmitted_by congenital method, and transmitted_by contaminated needles. The virus infects helper T cells (CD4+ T cells) which are directly or indirectly destroyed, macrophages, and dendritic cells. The infection has_symptom diarrhea, has_symptom fatigue, has_symptom fever, has_symptom vaginal yeast infection, has_symptom headache, has_symptom mouth sores, has_symptom muscle aches, has_symptom sore throat, and has_symptom swollen lymph glands.\n","propLabel":"applies to disease","valueLabel":"Human immunodeficiency virus infectious disease","valueURI":"http://purl.obolibrary.org/obo/DOID_526","valueAbbrev":"obo:DOID_526","propURI":"http://www.bioassayontology.org/bao#BAX_0000010"},{"propAbbrev":"bao:BAX_0000002","descr":"Binding assays are performed to understand the interaction between two molecules, e.g. perturbagen-protein, protein-protein, protein-DNA, etc.","propLabel":"has bioassay type","valueLabel":"binding type","valueURI":"http://www.bioassayontology.org/bao#BAO_0000041","valueAbbrev":"bao:BAO_0000041","propURI":"http://www.bioassayontology.org/bao#BAX_0000002"},{"propAbbrev":"bao:BAX_0000003","descr":"","propLabel":"has assay design method","valueLabel":"fluorescent ligand binding method","valueURI":"http://www.bioassayontology.org/bao#BAO_0002755","valueAbbrev":"bao:BAO_0002755","propURI":"http://www.bioassayontology.org/bao#BAX_0000003"},{"propAbbrev":"bao:BAX_0000005","descr":"","propLabel":"has target","valueLabel":"HIV-1 nucleocapsid protein, NC; https://www.ncbi.nlm.nih.gov/protein/247852","valueAbbrev":"","propURI":"http://www.bioassayontology.org/bao#BAX_0000005"}],"schemaURI":"http://www.bioassayontology.org/bas#","text":"HIV-1 nucleocapsid protein (HIV-1 NC) is a small (6.5 kDa) basic zinc-finger protein which participates in packaging of viral genomic RNA. The spacing and metal-chelating residues (3 Cys, 1 His) of the Cys-X2-Cys-X4-His-X4-Cys Zn fingers are conserved among all known retroviruses. HIV-1 NC was assayed for its binding to the consensus sequence single-stranded 5'-TGTGTGTG. The assay utilizes fluorescence polarization (FP) where probe TGx4F (fluorescein-labeled 5'-TGTGTGTG) exhibiting low polarization is mixed with HIV-1 NC. The protein-probe complex exhibited high polarization, whereas inhibitors of that binding led to a drop in the FP value. High salt was included to increase the stringency of binding and inhibitor screen. Reducing agents and zinc were present to stabilize the nucleocapsid zinc-finger protein. Two uL of reagents were dispensed to 1536-well Kalypsys black plates. The plates were centrifuged for 1 min at 1000 rpm. Compounds and controls (20 nL) were transferred via Kalypsys PinTool. The plates were incubated for 1 hr at room temperature, and then read on ViewLux (Perkin-Elmer). High-throughput CCD imager using fluorescein polarization filter set and 45 seconds exposure time.","pubchemAID":346}